FDA Drug recall D-1323-2020
Gaviscon Regular Strength Liquid Antacid Cool Mint, 12 FL OZ (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0…
- FDA Drug
- Class II
- terminated
- Published 2020-06-24
On 2020-06-24 the FDA classified a Class II recall of Gaviscon Regular Strength Liquid Antacid Cool Mint, 12 FL OZ (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0… by Glaxosmithkline Consumer Healthcare Holdings, citing labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1323-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-05-28 |
| Published | 2020-06-24 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Glaxosmithkline Consumer Healthcare Holdings |
| Distribution | US |
Product
Gaviscon Regular Strength Liquid Antacid Cool Mint, 12 FL OZ (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-41
Reason
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Identifiers
| ndc | 0135-0094-41 |
|---|---|
| ndc | 0135-0094-42 |
| ndc | 0135-0095-41 |
| ndc | 0135-0574-01 |
| code_info | Lot #: 8H21C1, Exp 7/31/2020; 9B25C1, Exp 1/31/2021; 9D02C1, Exp 2/28/2021; 9G01C1, Exp 5/31/2021 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1323-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.